Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1671868

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1671868

Fusion Biopsy Market, By Biopsy Route, By Product, By Application, By End User, By Geography

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The Global Fusion Biopsy Market is estimated to be valued at USD 791.1 Mn in 2025and is expected to reach USD 1,418.2 Mn by 2032 exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 791.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.70% 2032 Value Projection: USD 1,418.2 Mn
Figure. Fusion Biopsy Market Share (%), By Region, 2025
Fusion Biopsy Market - IMG1

Fusion biopsy combines two medical imaging technologies, magnetic resonance imaging (MRI), and ultrasound, to provide real-time image guidance for biopsy procedures with improved accuracy. It helps physicians locate suspicious tissue in the body and obtain tissue samples with minimal risk of sampling error or missing lesions. With rising cases of prostate, lung, and breast cancer worldwide, the demand for advanced biopsy techniques like fusion biopsy is increasing globally. Factors such as growing geriatric population, increasing awareness about early cancer diagnosis, technological advancements in medical imaging systems, and rising healthcare expenditure in developing countries are expected to drive the market growth during the forecast period.

Market Dynamics:

The global fusion biopsy market is driven by the rising prevalence of cancer, increasing preference for minimally invasive surgeries, and growing need for accurate tissue sampling techniques. According to WHO, cancer burden is expected to rise by over 70% in the next 20 years worldwide. Fusion biopsy aids in detecting cancers at an early stage with minimal chances of sampling errors. This is propelling its adoption globally. However, high installation and maintenance costs of fusion biopsy devices is restraining market growth. Opportunities for market players lie in expanding their regional presence in emerging markets, launching affordable devices and offering pay-per-use business models. Increasing approvals and launch of advanced devices integrated with artificial intelligence, robotics and 3D imaging technologies will also offer new opportunities in coming years. For example, in 2022, CMR Surgical, a medical equipment manufacturer, received breakthrough device designation from the U.S. FDA for its Versius surgical robotic system for soft tissue procedures.

Key Features of the Study:

This report provides in-depth analysis of the global fusion biopsy market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fusion biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GE Healthcare, Koninklijke Philips N.V., FUJIFILM Corporation, Siemens Healthineers, Hitachi, Ltd., Canon Medical Systems Corporation, Medtronic, Hologic, Inc., Varian Medical Systems, Boston Scientific Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., 3M Company, Carestream Health, and Neusoft Medical Systems Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fusion biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fusion biopsy market

Market Segmentation

  • Biopsy Route Insights (Revenue, USD Mn, 2020 - 2032)
    • Transrectal
    • Transperineal
  • Product Insights (Revenue, USD Mn, 2020 - 2032)
    • Equipment
    • MRI machines
    • Ultrasound devices
    • Fusion biopsy systems
    • Others
    • Consumables
    • Biopsy needles
    • Imaging contrast agents
    • Others
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Prostate Cancer
    • Others
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Care Centers
    • Academic & Research Laboratories
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • GE Healthcare
    • Koninklijke Philips N.V.
    • FUJIFILM Corporation
    • Siemens Healthineers
    • Hitachi, Ltd.
    • Canon Medical Systems Corporation
    • Medtronic
    • Hologic, Inc.
    • Varian Medical Systems
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Agilent Technologies, Inc.
    • 3M Company
    • Carestream Health
    • Neusoft Medical Systems Co., Ltd.
Product Code: CMI7697

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fusion Biopsy Market, By Biopsy Route
    • Global Fusion Biopsy Market, By Product
    • Global Fusion Biopsy Market, By Application
    • Global Fusion Biopsy Market, By End User
    • Global Fusion Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER's Analysis
    • Merger and Acquisition Scenario
    • Industry Trends

4. Global Fusion Biopsy Market, By Biopsy Route, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Transrectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Transperineal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Fusion Biopsy Market, By Product, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • MRI machines
    • Ultrasound devices
    • Fusion biopsy systems
    • Others
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Biopsy needles
    • Imaging contrast agents
    • Others

6. Global Fusion Biopsy Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Fusion Biopsy Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic & Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Fusion Biopsy Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • Medtronic
  • Hologic, Inc.
  • Varian Medical Systems
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • 3M Company
  • Carestream Health
  • Neusoft Medical Systems Co., Ltd.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!